dihexa administration method Buy 15mg | Third-Party Tested DIHEXA | Peptide Synthetic |

Some studies suggest BPC-157 may have anti-tumor properties, suppressing certain cancer markers while promoting healthy tissue repair

For labs with variable storage conditions or longer project timelines, this format provides meaningful protection against degradation

Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval

Experimental findings also point to possible neuroprotective properties, particularly in models examining brain health and neuronal support

Using unregulated "research chemical" products with unknown purity, incorrect concentrations, and potential contamination (bacterial endotoxins, heavy metals, residual solvents) introduces risks that have nothing to do with the peptide